Mutations in exon 12 of JAK2 are mainly found in JAK2 V617F-negative polycythaemia vera patients

British Journal of Haematology

Volumn 142, Issue 4, 2008, Pages 676-679

  Kouroupi, Eirini ^a   Zoi, Katerina ^b   Parquet, Nathalie ^a   Zoi, Christine ^b   Kiladjian, Jean Jacques ^a,c   Grigoraki, Vassiliki ^b   Vainchenker, William ^d   Lellouche, Franck ^e   Marzac, Christophe ^f   Schlageter, Marie Hélène ^a   Dosquet, Christine ^a   Scott, Linda M ^g   Fenaux, Pierre ^a,c   Loukopoulos, Dimitris ^h   Chomienne, Christine ^a   Cassinat, Bruno ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^c AVICENNE HOSPITAL   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e Hopital Laennec   (France)

^f HÔPITAL SAINT ANTOINE   (France)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h Center of Basic Research   (Greece)

Author keywords

Budd Chiari; Erythrocytosis; JAK2; Mutation; Polycythaemia; Thrombosis

Indexed keywords

JANUS KINASE 2;

ADOLESCENT; ADULT; AGED; ALLELE; BUDD CHIARI SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DNA DETERMINATION; ERYTHROCYTOSIS; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; GENE STRUCTURE; GENETIC IDENTIFICATION; HEMATOCRIT; HUMAN; LABORATORY DIAGNOSIS; LETTER; LEUKOCYTE COUNT; MALE; MUTATION RATE; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE COUNT; VEIN THROMBOSIS;

ADOLESCENT; ADULT; AGED; ERYTHROCYTE COUNT; EXONS; FEMALE; HUMANS; JANUS KINASE 2; MALE; MIDDLE AGED; MUTATION; POLYCYTHEMIA VERA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 47649122208     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2008.07223.x     Document Type: Letter

References (10)

1. Butcher, C.M., Hahn, U., To, L.B., Gecz, J., Wilkins, E.J., Scott, H.S., Bardy, P.G. D'Andrea, R.J 2007) Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients. Leukemia in press).
2. Kiladjian, J.J., Cassinat, B., Turlure, P., Cambier, N., Roussel, M., Bellucci, S., Menot, M.L., Massonnet, G., Dutel, J.L., Ghomari, K., Rousselot, P., Grange, M.J., Chait, Y., Vainchenker, W., Parquet, N., Abdelkader-Aljassem, L., Bernard, J.F., Rain, J.D., Chevret, S., Chomienne, C. Fenaux, P. (2006) High molecular response rate of polycythemia vera patients treated with pegylated interferon alpha-2a. Blood, 108, 2037 2040.
3. Pardanani, A., Lasho, T.L., Finke, C., Hanson, C.A. Tefferi, A. (2007) Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia, 21, 1960 1963.
4. Patel, R.K., Lea, N.C., Heneghan, M.A., Westwood, N.B., Milojkovic, D., Thanigaikumar, M., Yallop, D., Arya, R., Pagliuca, A., Gäken, J., Wendon, J., Heaton, N.D. Mufti, G.J. (2006) Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome. Gastroenterology, 130, 2031 2038.
5. Percy, M.J., Jones, F.G., Green, A.R., Reilly, J.T. McMullin, M.F. (2006) The incidence of the JAK2 V617F mutation in patients with idiopathic erythrocytosis. Haematologica, 91, 413 414.
6. Percy, M.J., Scott, L.M., Erber, W.N., Harrison, C.N., Reilly, J.T., Jones, F.G., Green, A.R. McMullin, M.F. (2007) The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Haematologica, 92, 1607 1614.
7. Pietra, D., Li, S., Brisci, A., Passamonti, F., Rumi, E., Theocharides, A., Ferrari, M., Gisslinger, H., Kralovics, R., Cremonesi, L., Skoda, R. Cazzola, M 2007) Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood in press).
8. Schlageter, M.H., Toubert, M.E., Podgorniak, M.P. Najean, Y. (1990) Radioimmunoassay of erythropoietin: analytical performance and clinical use in hematology. Clinical Chemistry, 36, 1731 1735.
9. Scott, L.M., Tong, W., Levine, R.L., Scott, M.A., Beer, P.A., Stratton, M.R., Futreal, P.A., Erber, W.N., McMullin, M.F., Harrison, C.N., Warren, A.J., Gilliland, D.G., Lodish, H.F. Green, A.R. (2007) JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. New England Journal of Medicine, 356, 459 468.
10. Williams, D.M., Kim, A.H., Rogers, O., Spivak, J.L. Moliterno, A.R. (2007) Phenotypic variations and new mutations in JAK2 V617F-negative polycythemia vera, erythrocytosis, and idiopathic myelofibrosis. Experimental Hematology, 35, 1641 1646.